Mechanisms regulating ribosome assembly and function in stem cells and vertebrate development.

干细胞和脊椎动物发育中核糖体组装和功能的调节机制。

基本信息

项目摘要

Protein synthesis underpins a cell’s decision to growth, proliferate and/or differentiate.2,6,11–14,14,15,18 Understanding how protein synthesis allow cells to perform these fundamental activities is a major challenge in biology. Therefore, there is a critical need to elucidate the mechanisms determining protein synthesis rates and whether these mechanisms operate in a cell type-specific manner to impart a new layer of regulation in the control of gene expression. To explore these questions, two orthogonal, but complementary, research programs, namely Program 1 and 2, have been designed. Program 1 investigates new factors and mechanisms involved in the regulated assembly of ribosomes in stem cells. Program 1 is built upon recent studies from my lab and others demonstrating that stem cells relies on ribosome assembly to ensure adequate protein synthesis rates and the transition from self-renewal to differentiation.2,3,6,11–14,14,15,18 My lab has characterized the composition of the small subunit (SSU) processome in human cells, and identified DNA-dependent protein kinase (DNA-PK) as an RNA-dependent regulator of ribosome assembly and proteins synthesis in hematopoietic stem cells.6 Thus, the immediate goal of Program 1 is to establish the mechanisms by which DNA-PK regulates ribosome biogenesis in stem cells. Program 2 explores how customizing ribosome assembly and function contributes to protein synthesis and selective mRNA translation during embryogenesis. Program 2 is underscored by recent findings suggesting that ribosomes composition and activity are dynamically regulated in a cell type- and tissue- specific manner, allowing protein expression to be regulated with exquisite temporal and spatial precision.8,12 The immediate goal of Program 2 is to generate in vivo model systems to understand how the cell creates and regulates ribosome heterogeneity and the importance of this form of regulation for proper cellular function and organismal development. To address these, we have generated transgenic zebrafish in which two compositionally distinct and developmentally regulated ribosomes have been genetically labeled, a unique and powerful tool to study functional aspects of the ribosome in an in vivo developmental model system. Over the next five years, we expect Program 1 and 2 to uncover new mechanisms regulating ribosomes assembly and function in stem cells and vertebrate development and to provide powerful insights into ribosomopathies, tissue- specific disorders linked to defects in ribosome biogenesis and function.
蛋白质合成是细胞决定生长、增殖和/或分化的基础。 理解蛋白质合成如何允许细胞执行这些基本活动是一项重大挑战 生物学。因此,迫切需要阐明决定蛋白质合成速率和蛋白质合成速率的机制。 这些机制是否以特定于细胞类型的方式运行,以在 基因表达的控制。为了探索这些问题,两个相互垂直但互补的研究计划, 即方案1和方案2已经设计完成。方案1调查涉及的新因素和新机制 在干细胞中核糖体的调节组装中。计划1建立在我实验室的最新研究基础上 其他人证明干细胞依赖核糖体组装来确保足够的蛋白质合成率 以及从自我更新到差异化的转变。2,3,6,11-14,14,15,18我的实验室已经表征了 人细胞中的小亚基(SSU)过程,并鉴定出DNA依赖的蛋白激酶(DNA-PK)是 一种依赖于RNA的造血干细胞核糖体组装和蛋白质合成的调节因子。 程序1的直接目标是建立DNA-PK调节核糖体的机制 干细胞的生物发生。计划2探索定制核糖体组装和功能如何有助于 胚胎发育过程中的蛋白质合成和选择性信使核糖核酸的翻译。计划2由最近的 研究结果表明,核糖体的组成和活性在一种细胞类型和组织中受到动态调节 特定的方式,允许以精细的时间和空间精度调节蛋白质的表达。8,12 程序2的直接目标是生成体内模型系统,以了解细胞是如何创建和 调节核糖体异质性以及这种形式的调节对正常细胞功能和 生物体发育。为了解决这些问题,我们培育了转基因斑马鱼,其中两种 成分独特且受发育调节的核糖体已被基因标记,一种独特的 在体内发育模型系统中研究核糖体功能的有力工具。超过了 未来五年,我们预计计划1和计划2将发现调节核糖体组装和 在干细胞和脊椎动物发育中的作用,并提供对核糖体疾病、组织- 与核糖体生物发生和功能缺陷相关的特定疾病。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A unified view of low complexity regions (LCRs) across species.
  • DOI:
    10.7554/elife.77058
  • 发表时间:
    2022-09-13
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Lee, Byron;Jaberi-Lashkari, Nima;Calo, Eliezer
  • 通讯作者:
    Calo, Eliezer
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eliezer Calo-Velazquez其他文献

Eliezer Calo-Velazquez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eliezer Calo-Velazquez', 18)}}的其他基金

Mechanisms regulating ribosome assembly and function in stem cells and vertebrate development.
干细胞和脊椎动物发育中核糖体组装和功能的调节机制。
  • 批准号:
    10274332
  • 财政年份:
    2021
  • 资助金额:
    $ 37.42万
  • 项目类别:
Mechanisms regulating ribosome assembly and function in stem cells and vertebrate development.
干细胞和脊椎动物发育中核糖体组装和功能的调节机制。
  • 批准号:
    10461099
  • 财政年份:
    2021
  • 资助金额:
    $ 37.42万
  • 项目类别:

相似国自然基金

UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
  • 批准号:
    82370264
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
活体动物线粒体biogenesis、fission及fusion对肝脏再生中能量供应影响机制的研究
  • 批准号:
    81470878
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目

相似海外基金

Biogenesis of the mitochondrial beta-barrel membrane protein at the intermembrane space.
膜间空间线粒体β-桶膜蛋白的生物发生。
  • 批准号:
    24K18071
  • 财政年份:
    2024
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
白血病幹細胞におけるRibosomal biogenesisの解明と治療戦略の構築
白血病干细胞核糖体生物发生的阐明和治疗策略的开发
  • 批准号:
    24H00639
  • 财政年份:
    2024
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
New mechanisms regulating the biogenesis of extracellular vesicles
调节细胞外囊泡生物发生的新机制
  • 批准号:
    DP240101427
  • 财政年份:
    2024
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Discovery Projects
DEL-1 Promotes Biogenesis of Mineralizing Extracellular Vesicles by Mediating Intracellular Calcium Signaling
DEL-1 通过介导细胞内钙信号传导促进矿化细胞外囊泡的生物合成
  • 批准号:
    24K19876
  • 财政年份:
    2024
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
MFB: Characterization of the Biogenesis, Uptake, and Cellular Response to the Ribonucleoprotein Cargoes of Extracellular Vesicles using EV-CLASP
MFB:使用 EV-CLASP 表征细胞外囊泡核糖核蛋白货物的生物合成、摄取和细胞反应
  • 批准号:
    2330665
  • 财政年份:
    2024
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Standard Grant
Mechanisms of PIKII-dependent transport during secretory granule biogenesis
分泌颗粒生物发生过程中 PIKII 依赖性运输的机制
  • 批准号:
    490594
  • 财政年份:
    2023
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Operating Grants
Changes in structure and biogenesis of Gram-negative envelope following a polymyxin challenge
多粘菌素攻击后革兰氏阴性包膜的结构和生物发生的变化
  • 批准号:
    BB/X000370/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Research Grant
MITOCHONDRIA REDOX BIOGENESIS AND METABOLIC RAMAN IMAGING IN INSULIN SIGNALLING
胰岛素信号传导中的线粒体氧化还原生物发生和代谢拉曼成像
  • 批准号:
    2883511
  • 财政年份:
    2023
  • 资助金额:
    $ 37.42万
  • 项目类别:
    Studentship
HIV particle morphology and biogenesis
HIV颗粒形态和生物发生
  • 批准号:
    10772748
  • 财政年份:
    2023
  • 资助金额:
    $ 37.42万
  • 项目类别:
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
  • 批准号:
    10735778
  • 财政年份:
    2023
  • 资助金额:
    $ 37.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了